Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, Nov....

Late-breaking poster presentations show HCB101's favorable safety, strong receptor occupancy, and promising monotherapy and combination activity in tumors historically unresponsive to...

In this free webinar, gain insight into best practices for collaboration between sponsors, CROs and IRBs to reduce revision cycles and increase predictability in timelines. The featured speakers...

Healthcare's most forward-thinking voices come together in a new collaborative series recorded at AI Med 2025. SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Outcomes Rocket and Censinet today announced the

Coreline Soft will introduce its groundbreaking chest AI platform AVIEW 2.0 at RSNA 2025 (November 30–December 4, Chicago), demonstrating how unified AI automation is fundamentally transforming...